Flo Health developed Flo, an AI-driven women’s health product that supports girls and women at every stage of their reproductive cycle (start of menstruation, cycle prediction, preparation for conception, pregnancy, early motherhood, and menopause).
Flo Health has raised €227M across 2 funding rounds from 3 investors, most recently a Series C round in Jul 2024. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2024-07-30 | Series C | €185M | General Atlantic | View deal → |
| 2021-09-08 | Series B | €42M | Target Global,VNV Global | View deal → |
